Crestone presents at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal. Oral Session: Discovery of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial Agent.
Enrollment is Now Open for the 19-0021 Clinical Study
